Articles tagged "surmount-trial"

Mounjaro (Tirzepatide): The Dual Agonist Explained

Mounjaro acts on 2 receptors (GLP-1 + GIP) with -22.5% weight loss in SURMOUNT trials. How it works, results, comparison with 1st and 3rd generation.